Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon Preskorn

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Innovations in Clinical Neuroscience|August 24, 2011
How Adaptive Trial Designs can Increase Efficiency in Psychiatric Drug Development: A Case StudyJoan Shen, Sheldon Preskorn, Vladimir Dragalin, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizersSheldon Preskorn, Albena Patroneva, Heather Silman, et al.
The International Journal of Neuropsychopharmacology|July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
Schizophrenia Research|November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA studyAlan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Innovations in Clinical Neuroscience|August 24, 2011
How Adaptive Trial Designs can Increase Efficiency in Psychiatric Drug Development: A Case StudyJoan Shen, Sheldon Preskorn, Vladimir Dragalin, et al.
Journal of Clinical Psychopharmacology|January 15, 2009
Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizersSheldon Preskorn, Albena Patroneva, Heather Silman, et al.
The International Journal of Neuropsychopharmacology|July 11, 2019
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, et al.
Schizophrenia Research|November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA studyAlan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Pageof 2